These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 1064138)

  • 1. Inhibition of gastric secretion by exogenous secretin and cholecystokinin in normals and duodenal ulcer patients.
    Jörgensen SP; Henriksen FW
    Scand J Gastroenterol Suppl; 1976; 37():39-42. PubMed ID: 1064138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined effect of glucagon and cholecystokinin on gastric secretion in man.
    Hendel L; Jörgensen SP; Christiansen J; Henriksen FW
    Scand J Gastroenterol Suppl; 1976; 37():43-6. PubMed ID: 1064139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings: A comparison of basal and stimulated gastric and pancreatic secretion in patients with and without duodenal ulcer disease.
    Gutierrez LV; Baron JH
    Gut; 1974 Oct; 15(10):836. PubMed ID: 4434957
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibitory effect of glucagon, secretin and caerulein on gastric acid secretion stimulated by pentagastrin in patients with duodenal ulcer.
    Kisfalvi I
    Acta Hepatogastroenterol (Stuttg); 1978 Dec; 25(6):487-91. PubMed ID: 726819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intragastric titration of peptone-stimulated gastric acid secretion.
    Kisfalvi I
    Acta Med Acad Sci Hung; 1978; 35(2):99-104. PubMed ID: 742344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretin snuff: evaluation of the action on pentagastrin-stimulated gastric acid secretion and on pancreatic bicarbonate production.
    Halter F; Witzel L; Kohler B; Hadorn B
    Scand J Gastroenterol; 1975; 10(1):81-5. PubMed ID: 1168364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of exogenous secretin and cholecystokinin (CCK) on pentagastrin-stimulated intrinsic factor (IF) secretion in man.
    Vatn MH; Berstad A; Myren J
    Scand J Gastroenterol; 1974; 9(3):313-18. PubMed ID: 4605241
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of secretin and cholecystokinin on gastric emptying and gastric secretion in man.
    Chey WY; Hitanant S; Hendricks J; Lorber SH
    Gastroenterology; 1970 Jun; 58(6):820-7. PubMed ID: 5423893
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of pentagastrin, exogenous secretin, and cholecystokinin (CCK) on the intrinsic factor (IF) secretion in man.
    Vatn MH
    Scand J Gastroenterol Suppl; 1974; 29():53-6. PubMed ID: 4610721
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction between secretin and cholecystokinin on inhibition of gastric secretion in man.
    Henriksen FW; Jörgensen SP; Möller S
    Scand J Gastroenterol; 1974 Nov; 9(8):735-40. PubMed ID: 4432044
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of glucagon on pentagastrin--and histamine--stimulated gastric acid secretion in patients with duodenal ulcer.
    Długosz J; Gabryelewicz A
    Acta Med Pol; 1979; 20(3):257-64. PubMed ID: 517164
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of parenteral secretin--cholecystokinin and of duodenal acid perfusion on gastric secretion in duodenal ulcer patients.
    Butt J; Yoshida T; Fleshler B
    Am J Dig Dis; 1977 Apr; 22(4):371-8. PubMed ID: 16484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics and duration of action of ranitidine on gastric secretion and its effect on pancreatic secretion in duodenal ulcer patients.
    Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
    Scand J Gastroenterol Suppl; 1981 Jun; 69():91-9. PubMed ID: 6119789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of basal and stimulated gastric acid and duodenal bicarbonate in patients with and without duodenal ulcer disease.
    Gutierrez LV; Baron JH
    Am J Gastroenterol; 1976 Sep; 66(3):270-6. PubMed ID: 998591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of highly selective vagotomy on exocrine pancreatic function in man.
    Lindskov J; Amtorp O; Larsen HR
    Gastroenterology; 1976 Apr; 70(4):545-9. PubMed ID: 1254138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease in gastric secretion during the first three months after proximal gastric vagotomy in duodenal ulcer patients.
    Roland M; Berstad A; Liavåg I
    Scand J Gastroenterol; 1975; 10(4):363-7. PubMed ID: 1098130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric secretory response to graded doses of pentagastrin alone or in combination with carbacholine in unoperated duodenal ulcer patients.
    Roland M
    Scand J Gastroenterol; 1975; 10(6):603-8. PubMed ID: 1101365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of secretin on gastric function in normal subjects and in patients with duodenal ulcer.
    Dalton MD; Eisenstein AM; Walsh JH; Fordtran JS
    Gastroenterology; 1976 Jul; 71(1):24-9. PubMed ID: 1278646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: Secretin release in man after intra-duodenal acid.
    Bloom SR; Ward AS
    Gut; 1974 Apr; 15(4):338. PubMed ID: 4834563
    [No Abstract]   [Full Text] [Related]  

  • 20. [Test of gastric secretion. Evaluation and interpretation].
    Gutiérrez Samperio C
    Prensa Med Mex; 1970; 35(11):429-37. PubMed ID: 5517603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.